immunotoxin mdna55 (1)

By Christine Davis

    Boca Raton Regional Hospital’s Marcus Neuroscience Institute has initiated a phase-two clinical trial of the immunotoxin MDNA55 in the treatment of patients with recurrent malignant brain tumors.
    Highly toxic to brain tumor

Read more…